Please Subscribe to get a daily link to Pat's blog via email


Your privacy is important to us. We will never spam you and keep your personal data secure.

Monthly Archives: October 2009

11 10, 2009

Carfilzomid Better Than Velcade?

Tags: , , , , |0 Comments

Did you all see this?Preliminary results from an ongoing Phase 1 clinical trial indicate that carfilzomib, a new proteasome inhibitor, has significant therapeutic results in patients with relapsed myeloma. The Multiple Myeloma Research Consortium (MMRC) reported the results at the Joint ECCO 15-34th ESMO Multidisciplinary Congress, which was held in Berlin from September 20 to

5 10, 2009

Radiation Therapy & Stem Cell Transplants

Tags: , , , , , |0 Comments

Most oncologists know not to administer melphalan chemotherapy for myeloma patients that need stem cells harvested for possible transplant. But far fewer are aware of the negative effects radiation therapy can have on a patient's ability to mobilize stem cells into the blood for harvest. I had a very difficult time producing enough stem cells

5 10, 2009

What About Multiple Myeloma?

Tags: , , , , , , , |1 Comment

On my other blog, www.HelpWithCancer.Org, Pattie and I just commented about the NFL and how the league is helping to raise breast cancer awareness by having players and coaches wear pink shoe laces, hats and accessories before, during and after the games. Anyway, short and sweet, here is what we wrote:The NFL Looks Good In

4 10, 2009

Myelodysplastic Syndromes (MDS)

Tags: , , , , , |0 Comments

According to Cure Magazine, the successful myeloma chemotherapy drug, Revlimid, is also used to help patients with myelodysplastic syndromes. MDS is a catch-all diagnosis for a number of different blood disorders that usually require regular transfusion therapy. Use of Revlimid among certain types of MDS improved hemoglobin levels and close to 70% of these patients

2 10, 2009

New Comprehensive Myeloma Resource List

Tags: |0 Comments

Connecticut has a very large and active multiple myeloma support group. Affiliated with the IMF, the group has just launched a new Website. It is just getting started, so I wasn't too impressed. However, their technical assistance link for myeloma patients and caregivers is excellent! Very comprehensive. Click here to travel to their resource site.

1 10, 2009

Be Careful What You Wish For!

Tags: , , , , , , |0 Comments

The three novel chemotherapy agents (Revlimid, Velcade, Thalomid) now commonly used to treat multiple myeloma have been so successful it has created an unforeseen problem. According to Dr. Shaji Kumar with Mayo Clinic, improved outcomes for the majority of myeloma patients using these drugs makes it more difficult to bring other, new drugs to market.